| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.0019 | 1 |